Neoadjuvant chemotherapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and docetaxel
Crossref DOI link: https://doi.org/10.1007/s13277-015-3221-9
Published Online: 2015-02-15
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gu, Xi
Jia, Shi
Wei, Wei
Zhang, Wen-Hai
Text and Data Mining valid from 2015-02-15